Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Recent filings | ||||||
Filed 2024-03-27 17:12 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Lauren, Merendino
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$225,999
+25,000 vol $9.04 each |
75,000 | |
Filed 2024-03-27 17:06 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
100,000 | |
Filed 2024-03-27 17:05 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
Filed 2024-03-27 17:03 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
Filed 2024-03-27 17:02 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
Filed 2024-03-27 17:00 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
156,000 | |
Filed 2024-03-27 16:58 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
113,793 | |
Filed 2024-03-27 16:57 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
156,000 | |
Filed 2024-03-27 16:24 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$632,799
+70,000 vol $9.04 each |
207,000 | |
Filed 2024-03-27 16:21 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,807,999
+200,000 vol $9.04 each |
830,000 | |
Filed 2024-03-27 16:18 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$994,399
+110,000 vol $9.04 each |
835,000 | |
Filed 2024-03-27 16:16 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$994,399
+110,000 vol $9.04 each |
1,722,500 | |
Filed 2024-03-27 16:12 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,163,999
+350,000 vol $9.04 each |
2,618,896 | |
Older filings | ||||||
Filed 2024-03-05 13:34 Tx date 2024-03-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,232.12
-694 vol $8.98 each |
12,634 | |
Filed 2024-02-06 19:10 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,549
+1,718 vol $3.23 each |
15,740 | |
Filed 2024-02-06 19:09 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,549.14
-1,718 vol $3.23 each |
1,685,782 | |
Filed 2024-02-06 19:04 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-17,180
-1,718 vol $10.00 each |
14,022 | |
Filed 2024-02-06 19:04 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,549
+1,718 vol $3.23 each |
||
Filed 2024-02-06 18:59 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,615
+500 vol $3.23 each |
13,328 | |
Filed 2024-02-06 18:56 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,615
-500 vol $3.23 each |
1,685,282 | |
Filed 2024-02-06 18:53 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
||
Filed 2024-02-06 18:50 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-748,926.78
-72,782 vol $10.29 each |
13,328 | |
Filed 2024-02-06 18:49 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$235,085
+72,782 vol $3.23 each |
86,110 | |
Filed 2024-02-06 18:46 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-235,085.86
-72,782 vol $3.23 each |
1,612,500 | |
Filed 2024-02-06 13:19 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,020
-500 vol $10.04 each |
13,328 | |
Filed 2024-02-06 13:15 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
13,828 | |
Filed 2024-02-06 13:15 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
||
Filed 2024-02-06 13:01 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,419.50
-694 vol $9.25 each |
13,328 | |
Filed 2024-01-17 19:38 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5,549.14
-1,718 vol $3.23 each |
||
Filed 2024-01-17 19:38 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
10 - Acquisition or disposition in the public market
|
$-5,549.14
-1,718 vol $3.23 each |
1,685,782 | |
Filed 2024-01-12 14:29 Tx date 2023-11-06 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-12,500 vol |
30,002 | |
Filed 2024-01-12 14:28 Tx date 2023-10-30 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-17,502 vol |
42,502 | |
Filed 2024-01-11 16:35 Tx date 2024-01-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,270.89
-699 vol $6.11 each |
14,022 | |
Filed 2023-12-18 19:54 Tx date 2023-12-14 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$21,249
+9,223 vol $2.30 each |
65,765 | |
Filed 2023-11-23 19:33 Tx date 2023-10-24 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,662
+3,750 vol $3.91 each |
725,000 | |
Filed 2023-11-23 19:31 Tx date 2023-10-01 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,750 vol |
721,250 | |
Filed 2023-11-22 16:51 Tx date 2023-11-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$134,821
+23,529 vol $5.73 each |
784,404 | |
Filed 2023-11-09 16:02 Tx date 2023-11-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$98,661
+16,471 vol $5.99 each |
760,875 | |
Filed 2023-11-09 16:01 Tx date 2023-11-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$321,240
+60,000 vol $5.35 each |
744,404 | |
Filed 2023-07-07 18:37 Tx date 2023-06-06 |
$EPI
ESSA Pharma Inc. |
Lauren, Merendino
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2023-01-05 17:29 Tx date 2022-12-22 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,067
+21,367 vol $2.39 each |
53,475 | |
Filed 2023-01-05 13:43 Tx date 2022-12-30 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,974
+3,067 vol $2.60 each |
35,175 | |
Filed 2023-01-05 13:40 Tx date 2022-12-30 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$21,585
+8,302 vol $2.60 each |
33,343 | |
Filed 2023-01-05 13:36 Tx date 2022-12-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-83,088.28
-34,334 vol $2.42 each |
684,404 | |
Filed 2023-01-05 13:36 Tx date 2022-12-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-91,312.49
-37,889 vol $2.41 each |
718,738 | |
Filed 2023-01-05 13:35 Tx date 2022-12-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110,351.01
-43,617 vol $2.53 each |
756,627 | |
Filed 2023-01-05 13:34 Tx date 2022-12-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-133,500
-50,000 vol $2.67 each |
800,244 | |
Filed 2023-01-05 13:33 Tx date 2022-12-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-143,000
-50,000 vol $2.86 each |
850,244 | |
Filed 2023-01-05 13:32 Tx date 2022-12-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-92,800
-32,000 vol $2.90 each |
900,244 | |
Filed 2023-01-05 13:32 Tx date 2022-12-14 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-75,000
-25,000 vol $3.00 each |
932,244 | |
Filed 2022-11-03 18:37 Tx date 2021-05-26 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
72 - Other settlement of third party derivative
|
+3,622 vol |
28,622 | |
Filed 2022-10-27 14:44 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
1,687,500 | |
Filed 2022-10-27 13:42 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
89,000 | |
Filed 2022-10-27 13:40 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
630,000 | |
Filed 2022-10-27 13:35 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
89,000 | |
Filed 2022-10-27 13:33 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
725,000 | |
Filed 2022-10-27 13:31 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
89,000 | |
Filed 2022-10-27 13:29 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
106,000 | |
Filed 2022-10-27 13:27 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
63,793 | |
Filed 2022-10-27 13:25 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
137,000 | |
Filed 2022-10-27 13:21 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
106,000 | |
Filed 2022-10-27 13:17 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+222,500 vol |
2,268,896 | |
Filed 2022-09-21 13:03 Tx date 2022-09-13 |
$EPI
ESSA Pharma Inc. |
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 | |
Filed 2022-09-21 12:58 Tx date 2022-09-13 |
$EPI
ESSA Pharma Inc. |
Kantoff, Philip Wayne
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-15 15:56 Tx date 2022-07-11 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: MSI BVF SPV, L.L.C. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$191,722
+72,076 vol $2.66 each |
186,788 | |
Filed 2022-07-15 15:55 Tx date 2022-07-08 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: MSI BVF SPV, L.L.C. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
114,712 | ||
Filed 2022-07-15 15:55 Tx date 2022-07-11 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Trading Fund O.S., L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$559,068
+210,176 vol $2.66 each |
357,472 | |
Filed 2022-07-15 15:54 Tx date 2022-07-08 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Trading Fund O.S., L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
147,296 | ||
Filed 2022-07-15 15:54 Tx date 2022-07-11 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund II, L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,764,863
+1,791,302 vol $2.66 each |
3,491,779 | |
Filed 2022-07-15 15:53 Tx date 2022-07-08 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund II, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,700,477 | ||
Filed 2022-07-15 15:53 Tx date 2022-07-11 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund, L.P. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,922,346
+2,226,446 vol $2.66 each |
4,712,590 | |
Filed 2022-07-15 15:52 Tx date 2022-07-08 |
$EPI
ESSA Pharma Inc. |
BVF Partners L.P.
3 - 10% Security Holder of Issuer
Holder: Biotechnology Value Fund, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,486,144 | ||
Filed 2022-07-05 11:41 Tx date 2022-06-30 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,455
+4,887 vol $2.96 each |
32,108 | |
Filed 2022-01-28 13:13 Tx date 2022-01-10 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
72 - Other settlement of third party derivative
|
+31,382 vol |
56,382 | |
Filed 2021-07-07 16:21 Tx date 2021-07-06 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,306
+1,246 vol $9.88 each |
25,041 | |
Filed 2021-07-07 16:13 Tx date 2021-07-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,306
+1,246 vol $9.88 each |
14,721 | |
Filed 2021-07-07 16:11 Tx date 2021-07-06 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,306
+1,246 vol $9.88 each |
27,221 | |
Filed 2021-07-07 15:56 Tx date 2021-07-06 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,511
+153 vol $9.88 each |
5,124 | |
Filed 2021-07-04 16:38 Tx date 2021-06-30 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,938
+905 vol $9.88 each |
13,475 | |
Filed 2021-07-04 16:31 Tx date 2021-06-30 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,938
+905 vol $9.88 each |
23,795 | |
Filed 2021-07-04 16:27 Tx date 2021-06-30 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,938
+905 vol $9.88 each |
25,975 | |
Filed 2021-07-04 16:22 Tx date 2021-06-30 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,938
+905 vol $9.88 each |
4,971 | |
Filed 2021-03-03 18:25 Tx date 2021-02-22 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,539,000
+57,000 vol $27.00 each |
957,244 | |
Filed 2021-01-05 15:29 Tx date 2020-09-25 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,832
+1,380 vol $6.40 each |
8,460 | |
Filed 2020-12-31 12:58 Tx date 2020-12-30 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,247
+1,970 vol $5.20 each |
4,066 | |
Filed 2020-12-28 13:49 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+100,000 vol $7.00 each |
535,000 | |
Filed 2020-12-28 13:44 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$402,500
+57,500 vol $7.00 each |
482,500 | |
Filed 2020-12-14 16:31 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$402,500
+57,500 vol $7.00 each |
||
Filed 2020-12-14 15:55 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$700,000
+100,000 vol $7.00 each |
||
Filed 2020-12-15 15:57 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$402,500
+57,500 vol $7.00 each |
540,000 | |
Filed 2020-12-15 15:54 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$700,000
+100,000 vol $7.00 each |
635,000 | |
Filed 2020-12-15 15:47 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,400,000
+200,000 vol $7.00 each |
1,597,500 | |
Filed 2020-12-15 15:42 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,868,636
+266,948 vol $7.00 each |
2,046,396 | |
Filed 2020-12-15 13:56 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Brettman, Ari
1 - Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
66,500 | |
Filed 2020-12-15 13:51 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
66,500 | |
Filed 2020-12-15 13:45 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
66,500 | |
Filed 2020-12-15 13:40 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
66,500 | |
Filed 2020-12-15 12:50 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
83,500 | |
Filed 2020-12-14 18:49 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
41,293 | |
Filed 2020-12-14 18:45 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
83,500 | |
Filed 2020-12-14 16:39 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$175,000
+25,000 vol $7.00 each |
102,000 | |
Filed 2020-12-14 16:31 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$402,500
+57,500 vol $7.00 each |
482,500 | |
Filed 2020-12-14 15:55 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$700,000
+100,000 vol $7.00 each |
535,000 | |
Filed 2020-12-14 15:49 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,400,000
+200,000 vol $7.00 each |
1,397,500 | |
Filed 2020-12-14 15:44 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,868,636
+266,948 vol $7.00 each |
1,779,448 | |
Filed 2020-12-14 14:48 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,321.04
-2,184 vol $3.81 each |
31,566 | |
Filed 2020-12-14 14:48 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,136
-6,534 vol $4.00 each |
33,750 | |
Filed 2020-12-14 14:48 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-80,750
-25,000 vol $3.23 each |
40,284 | |
Filed 2020-12-14 14:47 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
65,284 | |
Filed 2020-12-14 14:47 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,629
+6,773 vol $4.67 each |
900,244 | |
Filed 2020-12-14 14:46 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
893,471 | |
Filed 2020-12-14 14:46 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
||
Filed 2020-12-14 14:45 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
884,753 | |
Filed 2020-12-14 14:45 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
859,753 | |
Filed 2020-12-14 14:44 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,629.91
-6,773 vol $4.67 each |
24,793 | |
Filed 2020-12-14 14:42 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$31,629
+6,773 vol $4.67 each |
||
Filed 2020-12-14 14:41 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
||
Filed 2020-12-14 14:40 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,136
+6,534 vol $4.00 each |
891,287 | |
Filed 2020-12-14 14:39 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
Filed 2020-12-14 14:38 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
||
Filed 2020-12-14 14:37 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,629.91
-6,773 vol $4.67 each |
||
Filed 2020-12-14 14:36 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,321.04
-2,184 vol $3.81 each |
||
Filed 2020-12-14 14:36 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,136
-6,534 vol $4.00 each |
||
Filed 2020-12-14 14:35 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-80,750
-25,000 vol $3.23 each |
||
Filed 2020-12-14 14:34 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
||
Filed 2020-12-14 14:33 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
Filed 2020-12-14 14:33 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
||
Filed 2020-12-14 14:33 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,136
+6,534 vol $4.00 each |
||
Filed 2020-12-14 14:33 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
Filed 2020-12-14 14:28 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
Filed 2020-12-14 14:25 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,321
+2,184 vol $3.81 each |
||
Filed 2020-12-14 14:24 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$26,136
+6,534 vol $4.00 each |
||
Filed 2020-12-14 14:23 Tx date 2020-12-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
Filed 2020-12-14 14:22 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$6,864
+1,716 vol $4.00 each |
||
Filed 2020-12-14 14:21 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$27,456
+6,864 vol $4.00 each |
||
Filed 2020-12-14 14:18 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$27,456
+6,864 vol $4.00 each |
||
Filed 2020-12-14 14:07 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-31,629.91
-6,773 vol $4.67 each |
||
Filed 2020-12-14 14:04 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,321.04
-2,184 vol $3.81 each |
||
Filed 2020-12-14 14:01 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-26,136
-6,534 vol $4.00 each |
||
Filed 2020-12-14 14:00 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-80,750
-25,000 vol $3.23 each |
||
Filed 2020-12-14 13:57 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
||
Filed 2020-12-14 13:57 Tx date 2020-12-03 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-6,864
-1,716 vol $4.00 each |
65,284 | |
Filed 2020-09-24 15:55 Tx date 2020-09-24 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,585
+1,500 vol $6.39 each |
7,080 | |
Filed 2020-09-24 15:53 Tx date 2020-09-23 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,712
+580 vol $6.40 each |
5,580 | |
Filed 2020-09-24 15:41 Tx date 2020-09-23 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,736
+5,740 vol $6.40 each |
39,490 | |
Filed 2020-08-25 13:59 Tx date 2020-08-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$171,024
+24,088 vol $7.10 each |
858,037 | |
Filed 2020-08-25 13:58 Tx date 2020-08-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$138,370
+19,529 vol $7.09 each |
833,949 | |
Filed 2020-08-25 13:57 Tx date 2020-08-19 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$349,280
+50,000 vol $6.99 each |
814,420 | |
Filed 2020-08-21 14:13 Tx date 2020-08-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$680,000
+100,000 vol $6.80 each |
764,420 | |
Filed 2020-08-21 14:12 Tx date 2020-08-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,600
+7,000 vol $6.80 each |
664,420 | |
Filed 2020-08-04 14:25 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,200,000
+200,000 vol $6.00 each |
3,573,053 | |
Filed 2020-08-04 14:23 Tx date 2019-08-27 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$3,408,986
+1,704,493 vol $2.00 each |
3,373,053 | |
Filed 2020-08-04 13:57 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,702,652 vol |
1,668,560 | |
Filed 2020-08-04 13:09 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$600,000
+100,000 vol $6.00 each |
657,420 | |
Filed 2020-08-04 13:03 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+25,000 vol $6.00 each |
25,000 | |
Filed 2020-08-04 13:02 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-04 12:51 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,998
+8,333 vol $6.00 each |
12,570 | |
Filed 2020-08-04 12:45 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,998
+8,333 vol $6.00 each |
25,070 | |
Filed 2018-04-25 17:24 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,702,651 vol |
||
Filed 2020-07-02 14:21 Tx date 2020-06-29 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,249
+2,096 vol $4.89 each |
2,096 | |
Filed 2020-07-02 14:21 Tx date 2018-07-15 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-02 14:19 Tx date 2020-06-29 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,718
+4,237 vol $4.89 each |
4,237 | |
Filed 2020-07-02 14:17 Tx date 2016-08-01 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-07-02 14:14 Tx date 2020-06-30 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,098
+2,000 vol $6.05 each |
22,890 | |
Filed 2020-07-02 14:13 Tx date 2020-06-29 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,410
+4,174 vol $4.89 each |
20,890 | |
Filed 2020-07-02 14:09 Tx date 2020-06-29 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$20,718
+4,237 vol $4.89 each |
16,737 | |
Filed 2020-06-18 14:36 Tx date 2020-06-15 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150.35
+31 vol $4.85 each |
16,716 | |
Filed 2020-03-02 18:34 Tx date 2020-03-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,584
+916 vol $5.00 each |
557,420 | |
Filed 2020-03-02 18:33 Tx date 2020-03-02 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$67,685
+14,094 vol $4.80 each |
556,504 | |
Filed 2020-02-24 13:39 Tx date 2020-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540,000
+100,000 vol $5.40 each |
542,410 | |
Filed 2020-02-20 16:20 Tx date 2020-02-20 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$270,000
+50,000 vol $5.40 each |
442,410 | |
Filed 2020-02-20 16:19 Tx date 2020-02-19 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$805,860
+150,000 vol $5.37 each |
392,410 | |
Filed 2020-02-20 16:17 Tx date 2020-02-19 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$158,764
+29,565 vol $5.37 each |
242,410 | |
Filed 2020-01-17 17:10 Tx date 2020-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-273,843 vol |
212,845 | |
Filed 2020-01-17 17:07 Tx date 2020-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-273,843 vol |
||
Filed 2019-11-05 12:06 Tx date 2019-11-04 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+200 vol $6.00 each |
16,685 | |
Filed 2019-11-01 15:50 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Brettman, Ari
1 - Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
50,000 | |
Filed 2019-11-01 15:46 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
50,000 | |
Filed 2019-11-01 15:44 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
50,000 | |
Filed 2019-11-01 15:42 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
50,000 | |
Filed 2019-11-01 15:39 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
67,000 | |
Filed 2019-11-01 15:35 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
67,000 | |
Filed 2019-11-01 15:32 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
67,000 | |
Filed 2019-11-01 15:26 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
77,000 | |
Filed 2019-11-01 15:11 Tx date 2019-11-01 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,350
+2,300 vol $4.50 each |
16,485 | |
Filed 2019-11-01 15:11 Tx date 2019-10-31 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$45,000
+100 vol $450.00 each |
14,185 | |
Filed 2019-11-01 15:04 Tx date 2019-10-31 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,255
+7,000 vol $4.61 each |
486,688 | |
Filed 2019-10-22 09:58 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Brettman, Ari
1 - Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
25,000 | |
Filed 2019-10-22 09:55 Tx date 2019-10-17 |
$EPI
ESSA Pharma Inc. |
Brettman, Ari
1 - Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-21 15:57 Tx date 2019-10-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,154
+2,000 vol $3.58 each |
464,688 | |
Filed 2019-10-18 17:16 Tx date 2019-10-18 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$55,140
+15,000 vol $3.68 each |
477,688 | |
Filed 2019-10-16 14:13 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,292,000
+400,000 vol $3.23 each |
425,000 | |
Filed 2019-10-16 14:10 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,065,900
+330,000 vol $3.23 each |
435,000 | |
Filed 2019-10-16 14:07 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,133,100
+970,000 vol $3.23 each |
1,197,500 | |
Filed 2019-10-16 14:04 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$553,848
+171,470 vol $3.23 each |
1,512,500 | |
Filed 2019-10-16 14:02 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,322,151
+1,028,530 vol $3.23 each |
1,341,030 | |
Filed 2019-10-16 13:58 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
25,000 | |
Filed 2019-10-16 13:57 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Zweifach, Sanford
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-16 13:55 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
25,000 | |
Filed 2019-10-16 13:53 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-16 13:49 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
25,000 | |
Filed 2019-10-16 13:48 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-10-16 13:42 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
Filed 2019-10-16 13:37 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
Filed 2019-10-16 13:33 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
Filed 2019-10-16 13:13 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
Filed 2019-10-16 13:09 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
Filed 2019-10-16 13:04 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$96,900
+30,000 vol $3.23 each |
52,000 | |
Filed 2019-10-09 18:37 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-95 vol |
2,505 | |
Filed 2019-10-09 18:35 Tx date 2015-05-29 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$925.00
+100 vol $9.25 each |
100 | |
Filed 2019-10-09 18:27 Tx date 2019-10-08 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,824
+6,400 vol $3.41 each |
14,085 | |
Filed 2019-10-03 18:17 Tx date 2019-10-02 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,025
+250 vol $4.10 each |
7,680 | |
Filed 2019-09-11 17:07 Tx date 2019-09-10 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$920.50
+350 vol $2.63 each |
7,430 | |
Filed 2019-09-11 12:11 Tx date 2019-09-09 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,520
+900 vol $2.80 each |
7,080 | |
Filed 2019-09-11 12:10 Tx date 2019-09-06 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,972
+680 vol $2.90 each |
6,180 | |
Filed 2019-08-30 14:04 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-47,500 vol |
2,500 | |
Filed 2019-08-28 11:08 Tx date 2019-08-27 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,899
+3,000 vol $2.30 each |
53,000 | |
Filed 2019-08-09 13:42 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,881 | ||
Filed 2019-08-09 13:31 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Martin, John Alexander
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,299 | ||
Filed 2019-07-19 12:15 Tx date 2018-07-15 |
$EPI
ESSA Pharma Inc. |
Cesano, Alessandra
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
25,000 | ||
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,299
+5,000 vol $5.06 each |
17,000 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,599
+10,000 vol $5.06 each |
22,000 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,050
+5,000 vol $3.81 each |
17,000 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,400
+40,000 vol $3.81 each |
227,500 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,249
+12,500 vol $5.06 each |
92,500 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,050
+5,000 vol $3.81 each |
17,000 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$95,250
+25,000 vol $3.81 each |
105,000 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$171,450
+45,000 vol $3.81 each |
312,500 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,050
+5,000 vol $3.81 each |
17,000 | |
Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,249
+12,500 vol $5.06 each |
92,500 | |
Filed 2018-10-22 Tx date 2018-10-18 |
$EPI
ESSA Pharma Inc. |
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-22 Tx date 2018-10-18 |
$EPI
ESSA Pharma Inc. |
Stampacchi, Otello
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,996
+12,000 vol $3.58 each |
12,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-190,000 vol |
80,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,330,000 vol |
270,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-3,562,500 vol |
187,500 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,520,000 vol |
80,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-47,500 vol |
267,500 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-5,035,000 vol |
315,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-95,000 vol |
5,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-641,250 vol |
33,750 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Beekman, Hugo
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,520,000 vol |
80,000 | |
Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,744,831 vol |
144,465 | |
Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-237,500 vol |
12,500 | |
Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,702,651 vol |
1,668,561 | |
Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-3,314,204 vol |
462,688 | |
Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-2,744,831 vol |
141,465 | |
Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,400
+120,000 vol $0.245 each |
240,000 | |
Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,400
+120,000 vol $0.245 each |
120,000 | |
Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-96,000
-120,000 vol $0.80 each |
0 | |
Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,425
+165,000 vol $0.245 each |
240,000 | |
Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,375
+75,000 vol $0.245 each |
75,000 | |
Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-60,000
-75,000 vol $0.80 each |
0 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$324,625
+1,325,000 vol $0.245 each |
1,600,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,000
+200,000 vol $0.245 each |
275,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,375
+75,000 vol $0.245 each |
75,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-400,000
-200,000 vol $2.00 each |
0 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-60,000
-75,000 vol $0.80 each |
200,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$692,000
+3,460,000 vol $0.20 each |
3,750,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$58,000
+290,000 vol $0.20 each |
290,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$750,000
+3,750,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-1,012,100
-290,000 vol $3.49 each |
0 | |
Filed 2018-03-05 Tx date 2018-03-05 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-240,000
-300,000 vol $0.80 each |
1,600,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$392,000
+1,600,000 vol $0.245 each |
1,900,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+240,000 vol $0.20 each |
240,000 | |
Filed 2018-03-05 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Requadt, Scott
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+600,000 vol $0.20 each |
5,350,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$10,000
+50,000 vol $0.20 each |
4,750,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$10,000
+50,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$130,000
+650,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$940,000
+4,700,000 vol $0.20 each |
4,700,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,070,000
+5,350,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$940,000
+4,700,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,070,000
+5,350,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,070,000
+5,350,000 vol $0.20 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-600,000 vol |
0 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-50,000 vol |
600,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,000
+190,000 vol $0.20 each |
240,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+50,000 vol $0.20 each |
50,000 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-267,500
-50,000 vol $5.35 each |
0 | |
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Beekman, Hugo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,000
+240,000 vol $0.20 each |
240,000 | |
Filed 2018-03-05 Tx date 2018-03-05 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-240,000
-300,000 vol $0.80 each |
||
Filed 2018-03-05 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$392,000
+1,600,000 vol $0.245 each |
1,600,000 | |
Filed 2018-03-05 Tx date 2018-01-31 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-240,000
-300,000 vol $0.80 each |
0 | |
Filed 2018-02-09 Tx date 2018-01-09 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$6,250,000
+31,250,000 vol $0.20 each |
33,371,212 | |
Filed 2018-02-06 Tx date 2018-02-02 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,500
+50,000 vol $0.27 each |
50,000 | |
Filed 2018-02-06 Tx date 2014-12-08 |
$EPI
ESSA Pharma Inc. |
Wood, David Sidney
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-30 Tx date 2018-01-16 |
$EPI
ESSA Pharma Inc. |
Beekman, Hugo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-19 Tx date 2018-01-18 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,717
+29,856 vol $0.225 each |
||
Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,396
+40,000 vol $0.2099 each |
3,776,892 | |
Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,500
+150,000 vol $0.21 each |
3,736,892 | |
Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,848
+58,400 vol $0.22 each |
3,586,892 | |
Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,848
+58,400 vol $0.22 each |
||
Filed 2018-01-19 Tx date 2018-01-17 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,717
+29,856 vol $0.225 each |
3,528,492 | |
Filed 2018-01-19 Tx date 2018-01-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+10,000 vol $0.21 each |
3,498,636 | |
Filed 2018-01-19 Tx date 2018-01-16 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,100
+10,000 vol $0.21 each |
||
Filed 2018-01-16 Tx date 2018-01-09 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$50,000
+250,000 vol $0.20 each |
250,000 | |
Filed 2018-01-16 Tx date 2015-06-24 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-01-16 Tx date 2018-01-09 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$625,000
+3,125,000 vol $0.20 each |
3,488,636 | |
Filed 2016-08-12 Tx date 2016-08-09 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,012,100
+290,000 vol $3.49 each |
290,000 | |
Filed 2016-08-09 Tx date 2016-08-01 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-03-23 Tx date 2016-03-21 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,111,698
-370,566 vol $3.00 each |
2,886,296 | |
Filed 2016-03-22 Tx date 2016-03-21 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,111,698
-370,566 vol $3.00 each |
2,889,296 | |
Filed 2016-02-02 Tx date 2016-01-29 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-120,000 vol $0.50 each |
300,000 | |
Filed 2016-02-02 Tx date 2016-01-29 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$53,431
+106,862 vol $0.50 each |
3,259,862 | |
Filed 2016-02-02 Tx date 2016-01-29 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-120,000 vol $0.50 each |
300,000 | |
Filed 2016-02-02 Tx date 2016-01-29 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$53,431
+106,862 vol $0.50 each |
3,256,862 | |
Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
3,181,818 | ||
Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,212 | ||
Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-15 Tx date 2016-01-12 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
650,000 | |
Filed 2016-01-15 Tx date 2016-01-12 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
150,000 | |
Filed 2015-12-07 Tx date 2015-06-24 |
$EPI
ESSA Pharma Inc. |
Parkinson, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2015-10-16 Tx date 2015-10-09 |
$EPI
ESSA Pharma Inc. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-70,000 vol |
675,000 | |
Filed 2015-10-12 Tx date 2015-10-09 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-840.00
-120 vol $7.00 each |
3,150,000 | |
Filed 2015-10-12 Tx date 2015-10-07 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$807.84
+120 vol $6.73 each |
3,150,120 | |
Filed 2015-09-25 Tx date 2015-09-24 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,389
+3,600 vol $9.00 each |
2,504,800 | |
Filed 2015-09-01 Tx date 2015-08-31 |
$EPI
ESSA Pharma Inc. |
Sadar, Marianne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-167,200
-22,000 vol $7.60 each |
3,153,000 | |
Filed 2015-09-01 Tx date 2015-08-31 |
$EPI
ESSA Pharma Inc. |
Andersen, Raymond
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-190,000
-25,000 vol $7.60 each |
3,150,000 | |
Filed 2015-07-14 Tx date 2015-01-27 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SPOUSE (Indirect Ownership)
|
Special Warrants
54 - Exercise of warrants
|
-100 vol |
0 | |
Filed 2015-07-14 Tx date 2014-12-08 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SPOUSE (Indirect Ownership)
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
100 | ||
Filed 2015-07-14 Tx date 2015-01-27 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-200 vol |
0 | |
Filed 2015-07-14 Tx date 2014-12-08 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
200 | ||
Filed 2015-07-14 Tx date 2015-01-27 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+200 vol |
2,501,200 | |
Filed 2015-07-14 Tx date 2014-12-08 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-07-14 Tx date 2014-12-08 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,500,000 | ||
Filed 2015-07-14 Tx date 2015-01-27 |
$EPI
ESSA Pharma Inc. |
RIEDER, ROBERT
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: SPOUSE (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
+100 vol |
31,350 | |
Filed 2015-07-13 Tx date 2015-07-10 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Special Warrants
54 - Exercise of warrants
|
-363,636 vol |
0 | |
Filed 2015-07-13 Tx date 2015-07-10 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
+363,636 vol |
363,636 | |
Filed 2015-07-13 Tx date 2015-03-05 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-05 Tx date 2015-03-15 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-05 Tx date 2015-03-05 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
363,636 | ||
Filed 2015-06-05 Tx date 2015-03-05 |
$EPI
ESSA Pharma Inc. |
BERGER, FRANKLIN MILAN
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 |